Related Experiment Video
Updated: May 11, 2026
08:53
A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
Published on: January 10, 2025
[Erythropoietin in plastic surgery]
C I Günter1, F Rezaeian, Y Harder
1Klinik und Poliklinik für Plastische Chirurgie und Handchirurgie, Klinikum rechts der Isar, Technische Universität München, München. Christina.Guenter@lrz.tum.de
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V
|May 1, 2013
Summary
Erythropoietin (EPO) shows promise for tissue regeneration after trauma, aiding wound healing and nerve repair. However, more rigorous clinical trials are needed to confirm its benefits in plastic surgery.
Area of Science:
- Biochemistry and Endocrinology
- Regenerative Medicine
Context:
- Erythropoietin (EPO) is an endogenous hormone crucial for erythropoiesis, with a 30-year history in treating anemias.
- Recent research highlights EPO's pro-regenerative capabilities post-trauma, influencing cellular responses and tissue repair mechanisms.
Purpose:
- To review the established and emerging roles of Erythropoietin (EPO) in tissue regeneration.
- To evaluate the current evidence and limitations of EPO application in plastic surgery and wound healing.
Summary:
- EPO administration demonstrates short-term benefits like reduced primary injury response and apoptosis, and long-term effects including stem cell recruitment, growth factor release, angiogenesis, and re-epithelialization.
- Investigated applications in plastic surgery encompass free/local flaps, nerve regeneration, and enhancing healing in thermal and chronic wounds.
- Adverse effects include increased thromboembolic events, hypertension, and higher mortality in tumor-associated anemia patients.
Impact:
- The pro-regenerative effects of EPO suggest potential therapeutic applications beyond anemia, particularly in reconstructive and regenerative procedures.
- Current clinical evidence for EPO in plastic surgery is limited by a lack of Good Clinical Practice (GCP)-compliant trials, necessitating further high-quality research.
Related Concept Videos
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...